Welcome to CDC Stacks | Guidelines for vaccinating dialysis patients and patients with chronic kidney disease : summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP) - 30597 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Guidelines for vaccinating dialysis patients and patients with chronic kidney disease : summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP)
  • Published Date:
    June 2006
  • Language:
    English
Filetype[PDF - 139.79 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Guidelines for vaccinating dialysis patients and patients with chronic kidney disease; summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Chi, Carolyn; Moore, Matt; Murphy, Trudy V.; Patel, Priti R.; Pilishvili, Tamara; Strikas, Raymond A.;
    Corporate Author:
    United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.);
    Published:
    December 2012
    Description:
    This summary is not meant to apply to chronic kidney disease patients who are recently post-transplant. These patients are considered more significantly immunosuppressed than those who have only chronic kidney disease, with or without dialysis. Deter...
    Status:
    current
    File Type:
    Filetype[PDF - 833.32 KB]
  2. Guidelines for vaccinating pregnant women; abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Corporate Author:
    United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.);
    Published:
    March 2013
    Description:
    The table on the following page may be used to find the general rule for vaccinating a pregnant woman with a particular vaccine. The third column of the table refers the reader to the page in this document where more specific information from the app...
    File Type:
    Filetype[PDF - 1.46 MB]
  3. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-7):1-10.
    Description:
    This report summarizes and updates an earlier published statement issued by the Advisory Committee on Immunization Practices concerning the control and prevention of meningococcal disease (MMWR 1997:46[No. RR-5]:1-21) and provides updated recommendat...
    Status:
    superseded
    File Type:
    Filetype[PDF - 179.37 KB]
  4. Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Corporate Author:
    National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases.
    Published:
    May 27, 2005
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2005; 54(RR-7):1-21.
    Description:
    In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menactra, manufactured by Sanofi Pasteur, Inc., Swiftwater, Pennsylvania) was licensed for use among persons aged 11-55 years. CDCs Advisory Committee on Im...
    Status:
    superseded
    File Type:
    Filetype[PDF - 321.91 KB]
  5. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-5):1-10.
    Description:
    These recommendations update information regarding the polysaccharide vaccine licensed in the United States for use against disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135, as well as antimicrobial agents for chemoprophylaxis a...
    Status:
    superseded
    File Type:
    Filetype[HTML]